Stay updated with breaking news from Malik Slassi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mindset Pharma Inc. wishes to clarify certain disclosure in its management information circular dated September 19, 2023 for its special meeting of the Company's shareholders to approve a...
As the company enters 2022, it is progressing with investigational new drug-enabling studies for its lead candidate MSP-1014
Mindset Pharma Inc.: Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized Mindset Pharma Inc. (CSE: MSET) (" Mindset" or the " Company"), a drug discovery and development company focused on developing next generation psychedelic medicines and related technologies for the treatment of neuropsychiatric and neurological indications with unmet needs, is pleased to announce that it has filed another provisional patent application with the United States Patent and Trademark Offi...